基本資料
種類: ETF
費用比率%: 1.46
資產淨值: 12.57
成立日期: 26/06/2015
 
分析
市值分佈:
57.93%
大市值
12.24%
中市值
3.44%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 02/05/2026 06:10) 總持有投資項目: 67  
0%
 
100%
     10大 (28.57%)
代號 名稱 佔比% 持有日期
ZTSZOETIS1.5331/03/2026
LZAGFLonza Group AG1.5131/03/2026
WELLWelltower1.4331/03/2026
BSXBoston Scientific Corp1.0631/03/2026
DTILPrecision BioSciences1.0531/03/2026
IMTXImmatics NV0.9631/03/2026
PODDInsulet Corp0.9031/03/2026
PRQRProQR Therapeutics NV0.9031/03/2026
CVSCVS HEALTH Corp0.8831/03/2026
GPCRStructure Therapeutics0.8531/03/2026
CRLCharles River Laboratories International0.7931/03/2026
TEVATeva Pharmaceutical Industries Limited0.7631/03/2026
DOCHealthpeak Properties0.7531/03/2026
ZLABZai Lab Limited0.7531/03/2026
BDXBecton Dickinson and Co0.7431/03/2026
INSPInspire Medical Systems0.7431/03/2026
IQVIQVIA Holdings0.7131/03/2026
DSRLFDiasorin S.R.L.0.7031/03/2026
AAVXFAbivax SA0.6931/03/2026
BMYBristol-Myers Squibb Co0.6831/03/2026
  1   2    3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.